PMC:7652766 / 32276-32568
Annnotations
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T75 | 82-94 | Phenotype | denotes | coagulopathy | http://purl.obolibrary.org/obo/HP_0003256 |
| T76 | 128-140 | Phenotype | denotes | coagulopathy | http://purl.obolibrary.org/obo/HP_0003256 |
| T77 | 142-145 | Phenotype | denotes | CAC | http://purl.obolibrary.org/obo/HP_0003256 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T162 | 0-292 | Sentence | denotes | However, COVID-19 has some distinct features that may establish a new category of coagulopathy, denominated COVID-19 associated coagulopathy (CAC), whose main markers are higher D-dimer concentration and fibrinogen levels, a relatively lower platelet count, and longer prothrombin time (129). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1288 | 204-214 | Gene | denotes | fibrinogen | Gene:2244 |
| 1293 | 223-224 | Gene | denotes | a | Gene:351 |
| 1294 | 64-65 | Gene | denotes | a | Gene:351 |
| 1304 | 9-17 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1305 | 82-94 | Disease | denotes | coagulopathy | MESH:D001778 |
| 1306 | 108-116 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1307 | 128-140 | Disease | denotes | coagulopathy | MESH:D001778 |